Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
26 Feb 25 | GKOS Glaukos | Common Stock | Sell | Dispose S | No | No | 120.72 | 20,687 | 2.50 mm | 54,249 |
26 Feb 25 | GKOS Glaukos | Common Stock | Option exercise | Acquire M | No | No | 24.69 | 15,000 | 370.35 k | 74,936 |
26 Feb 25 | GKOS Glaukos | Common Stock | Option exercise | Acquire M | No | No | 32 | 25,000 | 800.00 k | 59,936 |
26 Feb 25 | GKOS Glaukos | Stock Option Common Stock | Option exercise | Dispose M | No | No | 24.69 | 15,000 | 370.35 k | 0 |
26 Feb 25 | GKOS Glaukos | Stock Option Common Stock | Option exercise | Dispose M | No | No | 32 | 25,000 | 800.00 k | 0 |
6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 84,686 | 0.00 | 0 |
6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 84,686 | 0.00 | 84,686 |
6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 27,933 | 0.00 | 0 |
4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | Yes | No | 3.65 | 110,913 | 404.83 k | 0 | |
4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | No | No | 3.65 | 996,935 | 3.64 mm | 27,933 |